ArticleAnnals of the rheumatic diseases2015

Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis.

D E A Greven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.